Development Time - Basic Report

Therapy	Phase I (months)	Phase II (months)	Phase III (months)	Pre-registration (months)	Registered (months)	Total (months)
	Mean	Mean	Mean	Mean	Mean	Mean
Hypolipaemic/Antiatherosclerosis, C10	17	27	23	16	4	114
Antidiabetic, A10B	19	31	27	19	7	122
Dependence treatment, N9A	21	21	28	6
Anorectic/Antiobesity, A8A3	23	41	37	17	2	148